Clinical Trial

Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)

Name: Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF) — clinical trial record (NCT06874894)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NOAC

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

This study was design to investigate the efficacy and safety of NOAC therapy in Koreans

Protocol Amendment History 1 change

notable Sponsor changed: Chung-Ang University Hosptial, Chung-Ang University College of Medicine -> Chung-Ang University Hospital 2026-06-21

Trial Details

NCT Number	NCT06874894
Lead Sponsor	Chung-Ang University Hosptial, Chung-Ang University College of Medicine Collaborators: Chung-Ang University Gwangmyeong Hospital, Samsung Medical Center, Korea University Ansan Hospital, Kosin University Gospel Hospital, Keimyung University Dongsan Medical Center, Yuhan Corporation
Conditions	Fibrillation, Atrial
Enrollment	1,021 participants
Start Date	2022-05-25
Primary Completion	2026-08-30 (estimated)
Study Completion	2026-08-30 (estimated)
Updated on ClinicalTrials.gov	2025-12-29